- Home
- APP vs MRK Comparison
APP vs MRK Comparison
Compare APP & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APP
- MRK
- Stock Information
- Founded
- APP 2012
- MRK 2000
- Country
- APP United States
- MRK United States
- Employees
- APP N/A
- MRK N/A
- Industry
- APP EDP Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- APP Technology
- MRK Health Care
- Exchange
- APP Nasdaq
- MRK Nasdaq
- Market Cap
- APP 219.7B
- MRK 198.5B
- IPO Year
- APP 2021
- MRK N/A
- Fundamental
- Price
- APP $634.55
- MRK $87.41
- Analyst Decision
- APP Buy
- MRK Buy
- Analyst Count
- APP 21
- MRK 14
- Target Price
- APP $569.05
- MRK $103.54
- AVG Volume (30 Days)
- APP 11.1M
- MRK 14.1M
- Earning Date
- APP 11-05-2025
- MRK 10-30-2025
- Dividend Yield
- APP N/A
- MRK 3.70%
- EPS Growth
- APP 198.85
- MRK 20.41
- EPS
- APP 7.03
- MRK 6.49
- Revenue
- APP $5,737,591,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- APP $20.53
- MRK $1.84
- Revenue Next Year
- APP $33.42
- MRK $5.24
- P/E Ratio
- APP $89.88
- MRK $13.51
- Revenue Growth
- APP 78.91
- MRK 1.82
- 52 Week Low
- APP $137.20
- MRK $73.31
- 52 Week High
- APP $745.61
- MRK $111.58
- Technical
- Relative Strength Index (RSI)
- APP 55.27
- MRK 60.55
- Support Level
- APP $545.00
- MRK $88.10
- Resistance Level
- APP $727.49
- MRK $91.00
- Average True Range (ATR)
- APP 38.99
- MRK 2.19
- MACD
- APP -10.31
- MRK 0.96
- Stochastic Oscillator
- APP 44.98
- MRK 73.62
About APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.